Using whole-genome sequencing to characterize clinically significant blood groups among healthy older Australians

Sudhir Jadhao, Candice Davison, Eileen V. Roulis, Simon Lee, Paul Lacaze, Moeen Riaz, John J. McNeil, David M. Thomas, Natalie M. Pecheniuk, Catherine A. Hyland, Robert L. Flower, Shivashankar H. Nagaraj

Research output: Contribution to journalArticleResearchpeer-review

1 Citation (Scopus)


There have been no comprehensive studies of a full range of blood group polymorphisms within the Australian population. This problem is compounded by the absence of any databases carrying genomic information on chronically transfused patients and low frequency blood group antigens in Australia. Here, we use RBCeq, a web server-based blood group genotyping software, to identify unique blood group variants among Australians and compare the variation detected vs global data. Whole-genome sequencing data were analyzed for 2796 healthy older Australians from the Medical Genome Reference Bank and compared with data from 1000 Genomes phase 3 (1KGP3) databases comprising 661 African, 347 American, 503 European, 504 East Asian, and 489 South Asian participants. There were 661 rare variants detected in this Australian sample population, including 9 variants that had clinical associations. Notably, we identified 80 variants that were computationally predicted to be novel and deleterious. No clinically significant rare or novel variants were found associated with the genetically complex ABO blood group system. For the Rh blood group system, 2 novel and 15 rare variants were found. Our detailed blood group profiling results provide a starting point for the creation of an Australian blood group variant database.

Original languageEnglish
Pages (from-to)4593-4604
Number of pages12
JournalBlood Advances
Issue number15
Publication statusPublished - 9 Aug 2022

Cite this